254 related articles for article (PubMed ID: 8267400)
1. 5q-: pathogenetic importance of the common deleted region and clinical consequences of the entire deleted segment.
Pedersen B
Anticancer Res; 1993; 13(5C):1913-6. PubMed ID: 8267400
[TBL] [Abstract][Full Text] [Related]
2. Deletions of chromosome 5 in malignant myeloid disorders.
Le Beau MM
Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
[TBL] [Abstract][Full Text] [Related]
3. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
MacKinnon RN; Kannourakis G; Wall M; Campbell LJ
Cancer Genet; 2011 Apr; 204(4):187-94. PubMed ID: 21536236
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
[TBL] [Abstract][Full Text] [Related]
5. 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics.
Eisenmann KM; Dykema KJ; Matheson SF; Kent NF; DeWard AD; West RA; Tibes R; Furge KA; Alberts AS
Oncogene; 2009 Oct; 28(39):3429-41. PubMed ID: 19597464
[TBL] [Abstract][Full Text] [Related]
6. Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML.
Pedersen B
Leukemia; 1996 Dec; 10(12):1883-90. PubMed ID: 8946926
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients.
Pedersen B; Jensen IM
Leukemia; 1991 Jul; 5(7):566-73. PubMed ID: 2072742
[TBL] [Abstract][Full Text] [Related]
9. Delineation by molecular cytogenetics of 5q deletion breakpoints in myelodyplastic syndromes and acute myeloid leukemia.
Royer-Pokora B; Trost D; Müller N; Hildebrandt B; Germing U; Beier M
Cancer Genet Cytogenet; 2006 May; 167(1):66-9. PubMed ID: 16682289
[TBL] [Abstract][Full Text] [Related]
10. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
[TBL] [Abstract][Full Text] [Related]
11. Submicroscopic deletions in 5q- associated malignancies.
Crescenzi B; La Starza R; Romoli S; Beacci D; Matteucci C; Barba G; Aventin A; Marynen P; Ciolli S; Nozzoli C; Martelli MF; Mecucci C
Haematologica; 2004 Mar; 89(3):281-5. PubMed ID: 15020265
[TBL] [Abstract][Full Text] [Related]
12. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
Galván AB; Mallo M; Arenillas L; Salido M; Espinet B; Pedro C; Florensa L; Serrano S; Solé F
Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chromosome 5 aberrations in complex karyotypes of patients with myeloid disorders reveals their contribution to dicentric and tricentric chromosomes, resulting in the loss of critical 5q regions.
Herry A; Douet-Guilbert N; Morel F; Le Bris MJ; Morice P; Abgrall JF; Berthou C; De Braekeleer M
Cancer Genet Cytogenet; 2007 Jun; 175(2):125-31. PubMed ID: 17556068
[TBL] [Abstract][Full Text] [Related]
15. [Parallel loss of c-FMS and GM-CSF genes in myeloid leukemias with 5q-chromosome].
Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohy H
Rinsho Ketsueki; 1991 Sep; 32(9):931-7. PubMed ID: 1942539
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).
Le Beau MM; Lemons RS; Espinosa R; Larson RA; Arai N; Rowley JD
Blood; 1989 Feb; 73(3):647-50. PubMed ID: 2783863
[TBL] [Abstract][Full Text] [Related]
17. 5q-: does longer survival of female patients explain the preponderance.
Pedersen B
Anticancer Res; 1997; 17(5A):3281-5. PubMed ID: 9413160
[TBL] [Abstract][Full Text] [Related]
18. Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears.
Bigoni R; Cuneo A; Milani R; Cavazzini F; Bardi A; Roberti MG; Agostini P; della Porta M; Specchia G; Rigolin GM; Castoldi G
Haematologica; 2001 Apr; 86(4):375-81. PubMed ID: 11325642
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
Sun Y; Cook JR
Leuk Res; 2010 Mar; 34(3):340-3. PubMed ID: 19608274
[TBL] [Abstract][Full Text] [Related]
20. Novel genes mapping to the critical region of the 5q- syndrome.
Boultwood J; Fidler C; Soularue P; Strickson AJ; Kostrzewa M; Jaju RJ; Cotter FE; Fairweather N; Monaco AP; Müller U; Lovett M; Jabs EW; Auffray C; Wainscoat JS
Genomics; 1997 Oct; 45(1):88-96. PubMed ID: 9339364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
